Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $254,856 | 127 | 71.0% |
| Travel and Lodging | $55,405 | 212 | 15.4% |
| Consulting Fee | $29,960 | 10 | 8.3% |
| Food and Beverage | $18,061 | 356 | 5.0% |
| Education | $597.35 | 11 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $234,136 | 348 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $72,323 | 131 | $0 (2024) |
| UROVANT SCIENCES INC | $26,374 | 44 | $0 (2022) |
| PFIZER INC. | $20,085 | 70 | $0 (2024) |
| Boston Scientific Corporation | $1,938 | 26 | $0 (2024) |
| COLOPLAST CORP | $1,425 | 19 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $323.66 | 7 | $0 (2021) |
| Dornier MedTech America, Inc | $305.14 | 3 | $0 (2019) |
| Astellas Pharma Global Development | $254.24 | 6 | $0 (2024) |
| Teleflex LLC | $181.50 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95,729 | 146 | Astellas Pharma US Inc ($67,449) |
| 2023 | $71,093 | 132 | Sumitomo Pharma America, Inc. ($45,594) |
| 2022 | $51,977 | 94 | Astellas Pharma US Inc ($28,334) |
| 2021 | $12,337 | 40 | Astellas Pharma US Inc ($7,650) |
| 2020 | $13,693 | 43 | Astellas Pharma US Inc ($9,810) |
| 2019 | $39,427 | 94 | Astellas Pharma US Inc ($28,801) |
| 2018 | $44,349 | 101 | Astellas Pharma US Inc ($37,793) |
| 2017 | $30,274 | 66 | Astellas Pharma US Inc ($29,638) |
All Payment Transactions
716 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: UROLOGY | ||||||
| 11/21/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $153.82 | General |
| Category: LithoVue_URO | ||||||
| 10/16/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Urology Gynecology | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $395.89 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $189.62 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $176.56 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Boston Scientific Corporation | — | Travel and Lodging | Cash or cash equivalent | $147.46 | General |
| Category: General - Therapies_ENDO | ||||||
| 08/29/2024 | Cook Medical LLC | NCIRCLE (Device) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Urology | ||||||
| 08/29/2024 | Boston Scientific Corporation | — | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: General - Therapies_ENDO | ||||||
| 08/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: HORMONE THERAPY | ||||||
| 08/06/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $25.54 | General |
| 08/06/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $8,400.00 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $90.75 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: Oncology | ||||||
| 07/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Oncology | ||||||
| 07/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $425.45 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 675 | 1,184 | $230,464 | $83,174 |
| 2022 | 12 | 602 | 994 | $206,986 | $77,558 |
| 2021 | 17 | 711 | 1,165 | $192,764 | $77,962 |
| 2020 | 21 | 765 | 1,168 | $215,144 | $75,270 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 522 | $133,728 | $48,513 | 36.3% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 26 | 29 | $21,428 | $8,713 | 40.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 36 | 41 | $20,070 | $7,463 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $12,436 | $4,646 | 37.4% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 26 | 29 | $11,328 | $4,599 | 40.6% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 16 | 29 | $4,466 | $1,801 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 27 | $4,920 | $1,771 | 36.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 25 | 25 | $4,200 | $1,697 | 40.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 118 | $3,776 | $1,187 | 31.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 59 | 86 | $4,300 | $729.20 | 17.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 23 | 26 | $6,188 | $686.34 | 11.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 54 | 83 | $1,992 | $633.78 | 31.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 22 | 25 | $1,204 | $498.73 | 41.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 71 | 107 | $428.00 | $235.40 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 440 | $110,832 | $41,879 | 37.8% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 34 | 35 | $26,628 | $10,900 | 40.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 33 | 39 | $19,080 | $7,491 | 39.3% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2022 | 34 | 35 | $14,008 | $5,923 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $14,214 | $4,688 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 54 | $9,544 | $3,064 | 32.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 109 | $3,456 | $1,102 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,144 | $936.60 | 29.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 56 | 76 | $3,558 | $616.76 | 17.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 38 | 52 | $1,236 | $423.21 | 34.2% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 16 | 19 | $970.00 | $361.09 | 37.2% |
About Dr. Nathaniel Barnes, M.D
Dr. Nathaniel Barnes, M.D is a Urology healthcare provider based in Webster, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033119516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathaniel Barnes, M.D has received a total of $358,880 in payments from pharmaceutical and medical device companies, with $95,729 received in 2024. These payments were reported across 716 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($254,856).
As a Medicare-enrolled provider, Barnes has provided services to 2,753 Medicare beneficiaries, totaling 4,511 services with total Medicare billing of $313,964. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Webster, TX
- Active Since 07/27/2005
- Last Updated 09/12/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1033119516
Products in Payments
- Xtandi (Drug) $104,846
- GEMTESA (Drug) $91,128
- MYRBETRIQ (Drug) $41,905
- XTANDI (Drug) $41,360
- Myrbetriq (Drug) $29,917
- MIRABEGRON (Drug) $14,315
- ORGOVYX (Drug) $927.14
- SPEEDICATH (Device) $474.60
- SpeediCath (Device) $435.47
- LithoVue (Device) $313.32
- Lithotripters & Accessories (Device) $305.14
- Porges Coloplast (Device) $189.46
- UroLift (Device) $165.75
- LITHOVUE (Device) $162.89
- ALTIS (Device) $139.57
- UROLIFT (Device) $138.76
- BMD-Inlay Ureteral Stent (Device) $134.21
- Olympus Laser Devices (Device) $125.00
- GENERAL THERAPIES (Device) $123.59
- Saxenda (Drug) $116.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Webster
Matthew Hoggatt, Md, MD
Urology — Payments: $67,137
Dr. Douglas Dow, M.d, M.D
Urology — Payments: $15,651
Dr. Jeromy Hackney, M.d, M.D
Urology — Payments: $8,356
Dr. Rohit Dhir, M.d, M.D
Urology — Payments: $5,492
Dr. Thanh Nguyen, Md, MD
Urology — Payments: $4,545
Dr. Joseph Sreshta, Md, MD
Urology — Payments: $3,227